Product Name
TRAIL Recombinant Rabbit Monoclonal Antibody [PSH14-40] - BSA and Azide free
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Recombinant protein within Human TRAIL aa 114-281.
Target Molecular Weight
Predicted band size: 33 kDa
Positive Control
786-0 cell lysate, 786-0.
Storage Instructions
Store at 2-8℃. Avoid freeze.
Purification Method
Protein A affinity purified.
Function
In the field of cell biology, TNF-related apoptosis-inducing ligand (TRAIL), is a protein functioning as a ligand that induces the process of cell death called apoptosis. TRAIL is a cytokine that is produced and secreted by most normal tissue cells. It causes apoptosis primarily in tumor cells, by binding to certain death receptors. TRAIL and its receptors have been used as the targets of several anti-cancer therapeutics since the mid-1990s, such as Mapatumumab. However, as of 2013, these have not shown significant survival benefit. TRAIL has also been implicated as a pathogenic or protective factor in various pulmonary diseases, particularly pulmonary arterial hypertension. TRAIL has also been designated CD253 (cluster of differentiation 253) and TNFSF10 (tumor necrosis factor (ligand) superfamily, member 10).
Background References
1. Sanmarco LM et al. Gut-licensed IFNgamma(+) NK cells drive LAMP1(+)TRAIL(+) anti-inflammatory astrocytes. Nature. 2021 Feb
2. Pimentel JM et al. The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer. Cancers (Basel). 2023 May
Synonyms
Apo 2 ligand antibody
APO 2L antibody
Apo-2 ligand antibody
Apo-2L antibody
APO2L antibody
CD253 antibody
CD253 antigen antibody
Chemokine tumor necrosis factor ligand superfamily member 10 antibody
Protein TRAIL antibody
TL2 antibody
Expand
Apo 2 ligand antibody
APO 2L antibody
Apo-2 ligand antibody
Apo-2L antibody
APO2L antibody
CD253 antibody
CD253 antigen antibody
Chemokine tumor necrosis factor ligand superfamily member 10 antibody
Protein TRAIL antibody
TL2 antibody
TNF Related Apoptosis Inducing Ligand antibody
TNF related apoptosis inducing ligand TRAIL antibody
TNF-related apoptosis-inducing ligand antibody
TNF10_HUMAN antibody
TNFSF10 antibody
TRAIL antibody
Tumor necrosis factor (ligand) family member 10 antibody
Tumor Necrosis Factor (ligand) Superfamily Member 10 antibody
Tumor necrosis factor apoptosis inducing ligand splice variant delta antibody
Tumor necrosis factor ligand superfamily member 10 antibody
Collapse
-
☑ Relative expression (RE)
This data was developed using HA723634, the same antibody clone in a different buffer formulation.
Western blot analysis of TRAIL on different lysates with Rabbit anti-TRAIL antibody (HA723634) at 1/5,000 dilution.
Lane 1: 786-0 cell lysate (20 µg/Lane)
Lane 2: HeLa cell lysate (negative)
Lysates/proteins at 20 µg/Lane.
Predicted band size: 33 kDa
Observed band size: 28/30 kDa
Exposure time: 25 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA723634) at 1/5,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
-
☑ Relative expression (RE)
This data was developed using HA723634, the same antibody clone in a different buffer formulation.
Flow cytometric analysis of HeLa (left, negative) and 786-0 (right, positive) cells labeling TRAIL.
Cells were fixed and permeabilized. Then stained with the primary antibody (HA723634, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"